Gender-affirming hormone therapy is linked to lower rates for moderate to severe depressive symptoms in transgender, ...

Victoria's former chief psychiatrist will lead a review into the provision of hormone therapy to children, after the ...

A newly published study of 3,592 transgender, nonbinary, and gender-diverse (TGD) patients found that 15% of patients with ...

Interval breast cancer rates have remained consistent over 30 years despite age-based screening, highlighting the need for ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

In a revealing video shared on her Instagram, Amy Schumer discussed her positive experience with hormone replacement therapy aimed at managing perimenopause. This phase, recognized by the Mayo Clinic ...

Independent lead reviewer appointed to examine paediatric gender hormone therapy Professor Ruth Vine has been appointed to lead an independent review ...

Red flag: Everybody goes through that. If your symptoms aren’t that bad, don’t worry about it. Red flag: If you’re still ...

Sherri Ozawa, MSN, RN, told The Post that serious blood loss during menstruation could be a symptom of a blood disorder that compromises the body’s ability to form blood clots.

The study also stressed that hormone therapy was integrated into each patient’s primary care, offered in an urban gender-affirming medical setting, and made accessible through affordable and low ...

Amy Schumer opens up about her weight loss journey, sharing her experiences with Ozempic and Mounjaro, and discusses her ...

HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...